Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Tarceva Following Concurrent Chemo-Radiotherapy as First Line Therapy in Patients With Unresectable Non-Small Cell Lung Cancer

NCT00466284 is registered in ClinicalTrials.gov with Grupo Gallego de Cancer de Pulmon as lead sponsor.

NCT NCT00466284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00466284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Tarceva Following Concurrent Chemo-Radiotherapy as First Line Therapy in Patients With Unresectable Non-Small Cell Lung Cancer
Lead sponsor
Grupo Gallego de Cancer de Pulmon
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2006
Completion date
Not reported
Enrollment
46
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer